Jansen Sandra, Vissers Lisenka E L M, de Vries Bert B A
Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Brain Sci. 2023 Jan 30;13(2):231. doi: 10.3390/brainsci13020231.
Intellectual disability (ID) has a prevalence of ~2-3% in the general population, having a large societal impact. The underlying cause of ID is largely of genetic origin; however, identifying this genetic cause has in the past often led to long diagnostic Odysseys. Over the past decades, improvements in genetic diagnostic technologies and strategies have led to these causes being more and more detectable: from cytogenetic analysis in 1959, we moved in the first decade of the 21st century from genomic microarrays with a diagnostic yield of ~20% to next-generation sequencing platforms with a yield of up to 60%. In this review, we discuss these various developments, as well as their associated challenges and implications for the field of ID, which highlight the revolutionizing shift in clinical practice from a phenotype-first into genotype-first approach.
智力残疾(ID)在普通人群中的患病率约为2%-3%,对社会有重大影响。ID的根本原因很大程度上源于遗传;然而,过去确定这种遗传原因往往需要漫长的诊断过程。在过去几十年里,遗传诊断技术和策略的进步使得这些病因越来越容易被检测到:从1959年的细胞遗传学分析,到21世纪的第一个十年,我们从诊断率约为20%的基因组微阵列发展到诊断率高达60%的新一代测序平台。在这篇综述中,我们讨论了这些不同的发展,以及它们给ID领域带来的相关挑战和影响,这些都凸显了临床实践从以表型为先到以基因型为先的革命性转变。